Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline for Creutzfeldt-Jakob disease: randomized double-blind placebo-controlled pilot study
2006-001858-27Phase 2Active
- Sponsor
- Carlo Besta Neurological Institute
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Creutzfeldt-Jakob disease (CJD) comparing Doxycycline arm with Placebo arm (2 arms). Primary endpoint: Survival time from randomization. Started Apr 2007; status: active.
02
Drugs
doxycycline
03
Conditions
Creutzfeldt-Jakob disease (CJD)
Beyond the preview
Go deeper on 2006-001858-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001858-27.